SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $246,762 | -27.3% | 71,113 | -2.6% | 0.02% | +33.3% |
Q2 2023 | $339,380 | +0.6% | 72,985 | 0.0% | 0.01% | +50.0% |
Q1 2023 | $337,191 | -45.8% | 72,985 | -5.3% | 0.01% | -27.3% |
Q4 2022 | $622,677 | +132.3% | 77,064 | +328.4% | 0.01% | +57.1% |
Q4 2021 | $268,000 | -61.9% | 17,988 | -51.7% | 0.01% | -46.2% |
Q3 2021 | $703,000 | -21.5% | 37,235 | -22.7% | 0.01% | -18.8% |
Q2 2021 | $896,000 | -22.8% | 48,186 | -5.4% | 0.02% | -20.0% |
Q1 2021 | $1,160,000 | -16.1% | 50,949 | -19.9% | 0.02% | -20.0% |
Q4 2020 | $1,382,000 | +226.7% | 63,646 | +51.1% | 0.02% | +92.3% |
Q3 2020 | $423,000 | – | 42,130 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |